Jan Grunewald

Company: AstraZeneca

Job title: Associate Director

Seminars:

Leveraging Delivery Approaches to Translate Oligonucleotide-Based Therapies for Different Indications 9:05 am

The success of oligonucleotide therapeutics hinges not only on target selection and chemistry but also on delivery strategies that can unlock extrahepatic targets and expand the reach of these modalities. While conjugate-based approaches have driven remarkable progress in hepatocyte delivery, new indications, from neuromuscular diseases to oncology, demand innovative delivery solutions to overcome biological barriers,…Read more

day: Pre-Conference Workshop Day